He did research in protein engineering at Genentech, was a founder, president and chief science officer at Sunesis Pharmaceuticals and is professor and former chair of
pharmaceutical chemistry at the University of California, San Francisco.
«Having different options to make iPSCs will be useful when scientists encounter challenges or difficulties with one approach,» said Ding, who is also a professor of
pharmaceutical chemistry at the University of California, San Francisco.
«Having different options to make iPSCs will be useful when scientists encounter challenges or difficulties with one approach,» said Ding, who is also a professor of
pharmaceutical chemistry at the UC San Francisco.
But Brian Shoichet, co-senior author on the Nature paper and professor in the department of
pharmaceutical chemistry at the University of California, San Francisco, says that they had another requirement, too, which was met by only a tiny subset of those molecules.
Delving deeper, Gopalkrishnan Saroja Seethapathy, a graduate student in
pharmaceutical chemistry at the University of Oslo, and colleagues randomly chose 3300 papers by Indian first authors from 350 journals flagged as predatory by Jeffrey Beall, a library scientist at the University of Colorado in Denver.
«Our findings could have a significant impact on the treatment of autoimmune diseases, as well as on stem cell and immuno - oncology therapies,» said Gladstone Senior Investigator Sheng Ding, PhD, who is also a professor of
pharmaceutical chemistry at the University of California, San Francisco.
Not exact matches
So, I took a job as a research scientist in the analytical lab of a smaller
chemistry - driven, discovery - based
pharmaceutical company located in Vancouver, B.C. With fewer than 100 employees and no products on the market, it couldn't have been further from the formal corporate work environment I was accustomed to
at a multinational company.
«This opens up entirely new opportunities in
pharmaceutical research and may lead to the discovery of new drugs,» says Yitzhak Apeloig, who specializes in organic
chemistry at the Technion Israel Institute of Technology in Haifa.
GC3 is a 10 - year initiative, launched in 2017 by Founding Director Leor Weinberger, PhD, senior investigator
at Gladstone, William and Ute Bowes Distinguished Investigator, and professor of
pharmaceutical chemistry, biochemistry and biophysics
at UC San Francisco (UCSF).
Dr. Ding, one of the world's leading chemical biologists in stem - cell science, earlier this year joined Gladstone and the faculty
at the University of California San Francisco (UCSF), as a professor of
pharmaceutical chemistry.
Dr. Ding is a senior investigator
at the Gladstone Institute of Cardiovascular Disease and a UCSF professor of
pharmaceutical chemistry.
A self - starter, she taught herself
chemistry over the summer prior to beginning her research, which is now being looked
at by
pharmaceutical researchers from Texas and other states.
Dr. Katrin Schuhen
at the University of Koblenz - Landau Organic and ecological
chemistry department, the group works on the next generation technologies needed to treat microplastics and
pharmaceuticals in wastewater.